Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2026-04-17 @ 5:04 PM
Study NCT ID:
NCT06571266
Status:
COMPLETED
Last Update Posted:
2025-05-16
First Post:
2024-08-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult Participants
Sponsor:
Organization: